AZN · Astrazeneca PLC · Metrics
$184.02
-0.43 (-0.23%)
At close · Nov 16
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$285.40B
Shares
1.55B
Volume · Nov 16
1.95M
Avg daily vol (3M)
3.03M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
AZN metrics
85 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$184.02
Market cap
$285.40B
Price action
23 metricsPrice change (1W)
-1.1%
Price change (30D)
+12.5%
Price change (3M)
+17.9%
Price change (6M)
+1.6%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$209.48
52-week low
$155.62
Change from 52-week high
-11.9%
Change from 52-week low
+18.5%
Annualized volatility
29.4%
Annualized volatility (3M)
27.4%
Implied volatility (30D)
23.0%
IV rank (1Y)
9.8
IV percentile (1Y)
6.0
Beta
0.1
RSI (14D)
61.9
Price vs SMA 50
+9.3%
Price vs SMA 200
—
Avg volume (3M)
3.05M
Relative volume
0.6
Average dollar volume
$511.55M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
1.55B
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.0×
reciprocal yield 19.9%
EV / EBITDA
—
EV / EBIT
22.1×
reciprocal yield 4.5%
P / sales
4.7×
reciprocal yield 21.5%
P / book
5.7
reciprocal yield 17.6%
FCF yield
3.7%
TTM · current market cap
Buyback yield
0.2%
P / FCF
26.8
reciprocal yield 3.7%
P / operating cash flow
20.9
reciprocal yield 4.8%
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
1.2%
Trailing 12 months
Payout ratio
46.9%
Shareholder yield
2.0%
Dividend / share (TTM)
$2.15
Dividend growth YoY
-31.2%
Dividend growth streak
2
Last ex-dividend
2026-02-19
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-30
Profitability
9 metricsGross margin
81.9%
Operating margin
22.8%
Trailing 12 months
Net margin
17.0%
Gross profit (TTM)
$50.25B
Operating profit (TTM)
$13.97B
Net income (TTM)
$10.45B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
17.4%
Effective tax rate
16.9%
Growth
11 metricsRevenue growth YoY
+6.4%
Year over year
Net income growth YoY
+2.3%
Revenue (TTM)
$61.37B
Trailing 12 months
EPS growth YoY
+2.5%
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
+9.8%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
+15.7%
EPS CAGR (5Y)
+6.0%
FCF CAGR (3Y)
+10.5%
FCF CAGR (5Y)
+25.1%
Quality
14 metricsReturn on equity
20.8%
Return on assets
9.0%
Debt / equity
0.6
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
$10.67B
Quick ratio
0.7
Interest coverage
8.0
Net debt / EBITDA
—
Return on invested capital
16.4%
Trailing 12 months
Net cash
−$22.11B
Latest balance sheet
Cash & equivalents
$5.71B
Total assets
$115.83B
Total debt
$27.82B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$13.70B
Capital expenditures (TTM)
$3.03B
R&D (TTM)
$15.07B
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
24.6%
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
1,227
13F filer change QoQ
-260
Institutional ownership
45.7%
Conviction holders (share of 13F filers)
3.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.1%
Holder tenure
2.9
Price vs estimated holder cost
-7.6%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.2%
Short interest
3 metricsShort interest
0.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
45 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
901832
CUSIP
G0593M107
13F (30d)
1094 filings
1075 filers
Visit website
Investor relations